Joseph Merola, Professor

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol-Myers Squibb
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Moonlake
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    UCB
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi-Regeneron
    Topic:
    Consulting and Research
    Date added:
    04/03/2024
    Date updated:
    04/03/2024

Pages

Return to Update in Internal Medicine 2025 (RP2505A)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.